This paper details the main factors influencing the performance of limestone calcined clay cements (LC³). The kaolinite content plays a major role in the rheological properties as well as strength development. Even in the presence of secondary phases, kaolinite can be accurately quantified by thermogravimetric analysis. The performance of LC³ is slightly influenced by the calcination process of clay, but it can be optimized by using the correct calcination temperature and applying a specific mix design with adjusted sulfate and alkali content. The hydration reactions of LC³ are fully characterized. They vary slightly from plain cement. There is no significant change in terms of phase assemblage. The main properties of LC³ are also described. LC³ blends show a lower creep compliance and a delay in shrinkage strains compared with plain cement. Concerning durability, LC³ blends show outstanding performance with respect to resisting chloride ingress and expansion from the alkali–silica reaction.

The use of calcined clays as supplementary cementitious materials provides the opportunity to significantly reduce the cement industry’s carbon burden; however, use at a global scale requires a deep understanding of the extraction and processing of the clays to be used, which will uncover routes to optimise their reactivity. This will enable increased usage of calcined clays as cement replacements, further improving the sustainability of concretes produced with them. Existing technologies can be adopted to produce calcined clays at an industrial scale in many regions around the world. This paper, produced by RILEM TC 282-CCL on calcined clays as supplementary cementitious materials (working group 2), focuses on the production of calcined clays, presents an overview of clay mining, and assesses the current state of the art in clay calcination technology, covering the most relevant aspects from the clay deposit to the factory gate. The energetics and associated carbon footprint of the calcination process are also discussed, and an outlook on clay calcination is presented, discussing the technological advancements required to fulfil future global demand for this material in sustainable infrastructure development.

The RILEM technical committee 282-CCL: Calcined Clays as Supplementary Cementitious Materials, investigates all the aspects related to calcined clays, from clay exploration and characterization to calcination process, hydration reactions and concrete properties. This white paper focuses on the hydration mechanisms of calcined clay-blended Portland cements, covering both 1:1 and 2:1 calcined clays. The pozzolanic reaction of calcined clay is detailed, and the main reaction products are described. The differences observed depending on the clay type are also discussed, as well as the potential influence of the secondary phases present in calcined clay. The factors controlling and limiting the reaction of calcined clay are investigated, evidencing the role of porosity saturation and refinement of the microstructure. The complete characterisation of the hydration of calcined clay cements is made possible by the determination of the reaction degree of calcined clay. Several methods are compared to estimate the extent of calcined clay reaction. The influence of clinker and limestone mineralogy are also discussed. Finally, guidelines for optimising the mixture design of calcined clay blended cements are provided, with special attention to sulphate adjustment and clinker factor.

The Repressor Element 1 Silencing Transcription factor (REST/NRSF) is a master repressor of neuronal programs in non-neuronal lineages shown to function as a central regulator of developmental programs and stem cell physiology. Aberrant REST function has been associated with a number of pathological conditions. In cancer biology, REST has been shown to play a tumor suppressor activity in epithelial cancers but an oncogenic role in brain childhood malignancies such as neuroblastoma and medulloblastoma. Here we examined REST expression in human glioblastoma multiforme (GBM) specimens and its role in GBM cells carrying self-renewal and tumorigenic competence. We found REST to be expressed in GBM specimens, its presence being particularly enriched in tumor cells in the perivascular compartment. Significantly, REST is highly expressed in self-renewing tumorigenic-competent GBM cells and its knock down strongly reduces their self-renewal in vitro and tumor-initiating capacity in vivo and affects levels of miR-124 and its downstream targets. These results indicate that REST contributes to GBM maintenance by affecting its self-renewing and tumorigenic cellular component and that, hence, a better understanding of these circuitries in these cells might lead to new exploitable therapeutic targets.